James Patrick Kelly, EVP & Chief Financial Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 18,310 shares at $15.35 ($281K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $281k VNDA by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.35 | 9,155 | $141K | 50.0% |
| 2 | $15.35 | 9,155 | $141K | 50.0% |
| Total | $15.35 avg | 18,310 | $281K | 100% |
| Filing → |
| VNDA | SELL | 2019-03-04 | $548K | — | Filing → |
| VNDA | SELL | 2019-01-04 | $232K | — | Filing → |
| CBT | SELL | 2018-06-08 | $160K | — | Filing → |